189 related articles for article (PubMed ID: 32251868)
1. Management of cerebral azole-resistant Aspergillus fumigatus infection: A role for intraventricular liposomal-amphotericin B.
Schauwvlieghe AFAD; Bredius RGM; Verdijk RM; Smiers FJW; van der Beek MT; Goemans BF; Zwaan CM; Brüggemann RJ; Rijnders BJA
J Glob Antimicrob Resist; 2020 Sep; 22():354-357. PubMed ID: 32251868
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
Seyedmousavi S; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Apr; 57(4):1866-71. PubMed ID: 23380732
[TBL] [Abstract][Full Text] [Related]
3.
Seyedmousavi S; Mouton JW; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416540
[TBL] [Abstract][Full Text] [Related]
4. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
[TBL] [Abstract][Full Text] [Related]
5.
Siopi M; Mouton JW; Pournaras S; Meletiadis J
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962332
[No Abstract] [Full Text] [Related]
6. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
7. [Azole-resistant invasive aspergillosis].
van der Linden JW; Warris A; van der Meer JW; Bresters D; Melchers WJ; Verweij PE
Ned Tijdschr Geneeskd; 2009; 153():A765. PubMed ID: 20051169
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
[TBL] [Abstract][Full Text] [Related]
10. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
[TBL] [Abstract][Full Text] [Related]
11. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.
Meis JF; Chowdhary A; Rhodes JL; Fisher MC; Verweij PE
Philos Trans R Soc Lond B Biol Sci; 2016 Dec; 371(1709):. PubMed ID: 28080986
[TBL] [Abstract][Full Text] [Related]
13. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
14. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
Kirchhoff L; Dittmer S; Furnica DT; Buer J; Steinmann E; Rath PM; Steinmann J
J Antimicrob Chemother; 2022 May; 77(6):1645-1654. PubMed ID: 35289361
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
[TBL] [Abstract][Full Text] [Related]
17. Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus.
Jeurissen A; Cooreman S; Van Kerckhoven W; Van Leemput J; Vanhove P; Lagrou K; Heytens L
Acta Clin Belg; 2012; 67(1):46-8. PubMed ID: 22480040
[TBL] [Abstract][Full Text] [Related]
18. Azole-resistant aspergillosis.
Warris A
J Infect; 2015 Jun; 71 Suppl 1():S121-5. PubMed ID: 25917808
[TBL] [Abstract][Full Text] [Related]
19. Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
Siopi M; Siafakas N; Vourli S; Zerva L; Meletiadis J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3973-83. PubMed ID: 25896699
[TBL] [Abstract][Full Text] [Related]
20. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
